Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More
In a Debate About Mitosis, New Study Links Process to Cell Size
Amnis® ImageStream®X Mk II imaging flow cytometry helps answer a longstanding question about what triggers cell mitosis
It has been more than 140 years since the discovery of the mitosis process, but until now, scientists were hard-pressed to explain what triggers cell division. The most common hypotheses have speculated that cells divide when they reach a particular size, when they’ve grown for a certain amount of time, or when they have amassed a specific volume.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
3 September
Luminex Corporation to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
31 July
Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend
11 July
Luminex Corporation Second Quarter Earnings Release Scheduled for July 31, 2019
1 July
Luminex Submits ARIES MRSA Assay for FDA Clearance
21 May
Luminex Corporation Declares Second Quarter Cash Dividend
